Regulation of Protein Translation and c-jun expression by Prostate Tumor Overexpressed1 (PTOV1)



Similar documents
Title: Immunohistochemical staining of radixin and moesin in prostatic adenocarcinoma

Notch 1 -dependent regulation of cell fate in colorectal cancer

PART 3.3: MicroRNA and Cancer

Wissenschaftliche Highlights der GSF 2007

Changes in Breast Cancer Reports After Second Opinion. Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain

CONTRACTING ORGANIZATION: University of Alabama at Birmingham Birmingham, AL 35294

micrornas Non protein coding, endogenous RNAs of 21-22nt length Evolutionarily conserved

The Diagnosis of Cancer in the Pathology Laboratory

Department of BioScience Technology Chung Yuan Christian University 2015/08/13

No Disclosures. Learning Objectives 10/25/13

TEXT PICTURE. Martin Puhr PhD. Medical University of Innsbruck. Department of Urology Division of Experimental Urology

Introduction to Pathology and Diagnostic Medicine

HER2 Testing in Breast Cancer

Using TaqMan Endogenous Control Assays to select an endogenous control for experimental studies

Lesson 3 Reading Material: Oncogenes and Tumor Suppressor Genes

Effects of Herceptin on circulating tumor cells in HER2 positive early breast cancer

Specific problems. The genetic code. The genetic code. Adaptor molecules match amino acids to mrna codons

OBJECTIVES By the end of this segment, the community participant will be able to:

Targeting Specific Cell Signaling Pathways for the Treatment of Malignant Peritoneal Mesothelioma

How To Understand And Understand The Business Of Advanced Marker Discovery

Publikationsliste Claudia Götz

microrna Signatures in Cancer E. ROBERT WASSMAN, MD, FAAP, FACMG CHIEF MEDICAL OFFICER, ROSETTA GENOMICS

CytoSelect 48-Well Cell Adhesion Assay (ECM Array, Colorimetric Format)

YOUR LUNG CANCER PATHOLOGY REPORT

Actions of Hormones on Target Cells Page 1. Actions of Hormones on Target Cells Page 2. Goals/ What You Need to Know Goals What You Need to Know

MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY

Successes and Limitations of Targeted Therapies in Renal Cell Carcinoma

MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY

Types of Cancers [-oma growth ]!

Outline. Workup for metastatic breast cancer. Metastatic breast cancer

GENE REGULATION. Teacher Packet

AP BIOLOGY 2009 SCORING GUIDELINES


H. Richard Alexander, Jr., M.D. Department of Surgery and The Greenebaum Cancer Center University of Maryland School of Medicine Baltimore, Md

Molekylært målrettet medicinsk kræftbehandling for klinikere principper og metoder

Diagnostic Challenge. Department of Pathology,

HAVE YOU BEEN NEWLY DIAGNOSED with DCIS?

Science Highlights. To PSA or not to PSA: That is the Question.

Control of Gene Expression

Lecture 7 Mitosis & Meiosis

Chris Braden. B.S. in Biology, Summa Cum Laude Linfield College, McMinnville, OR Major: Biology Minor: Chemistry Advisor: Dr.

Control of Gene Expression

Cancer SBL101. James Gomes School of Biological Sciences Indian Institute of Technology Delhi

PRIMARY SEROUS CARCINOMA OF PERITONEUM: A CASE REPORT

Understanding the immune response to bacterial infections

The following information is only meant for people who have been diagnosed with advanced non-small cell

PCA3 DETECTION TEST FOR PROSTATE CANCER DO YOU KNOW YOUR RISK OF HAVING CANCER?

<1 cm WDT-UMP, FT-UMP. Kakudo K et al, Pathol Int,2009, Endocr J, 2011 and Pathol Int, 2012

LESSON 3.5 WORKBOOK. How do cancer cells evolve? Workbook Lesson 3.5

Predictive Biomarkers for PD1 Pathway Inhibitor Immunotherapy

BAP1 germline mutations A new Cutaneous Nevus Melanoma Syndrome. Thomas Wiesner

TECHNICAL INSIGHTS TECHNOLOGY ALERT

What is Cancer? Cancer is a genetic disease: Cancer typically involves a change in gene expression/function:

WntResearch. Foxy-5 A unique Phase 1 opportunity to combat the spreading of cancer

Appendix C DNA Replication & Mitosis

Mechanism of short-term ERK activation by electromagnetic fields at mobile phone frequencies. Biochemistry Journal. August 1, , pp.

A 70-year old Man with Pleural Effusion

Advances in Diagnostic and Molecular Testing in Prostate Cancer

LCFA/IASLC LORI MONROE SCHOLARSHIP IN TRANSLATIONAL LUNG CANCER RESEARCH

Targeted Therapies in Lung Cancer

Cellular, Molecular, and Biochemical Targets in Breast Cancer

Special report. Chronic Lymphocytic Leukemia (CLL) Genomic Biology 3020 April 20, 2006

New strategies in anticancer therapy

A disease of populations of cells that live, divide, invade and spread without regard to normal limits

Prostate Cancer. Treatments as unique as you are

PSA Testing 101. Stanley H. Weiss, MD. Professor, UMDNJ-New Jersey Medical School. Director & PI, Essex County Cancer Coalition. weiss@umdnj.

Neoplasia gastrica cistica: GIST o leiomiosarcoma? Sebastiano Cacciaguerra U. O. Chirurgia Pediatrica Ospedale Garibaldi Catania

Uses of Flow Cytometry

PREPARED FOR: U.S. Army Medical Research and Materiel CommandFort Detrick, Maryland

A918: Prostate: adenocarcinoma

Identification of CD4+ T cell epitopes specific for the breast cancer associated antigen NY-BR-1

Pap smears, cytology and CCHC lab work and follow up

Luísa Romão. Instituto Nacional de Saúde Dr. Ricardo Jorge Av. Padre Cruz, Lisboa, Portugal. Cooper et al (2009) Cell 136: 777

Histologic Subtypes of Renal Cell Carcinoma

A novel molecular mechanism involved in cancer development revealed by targeting MafB to hematopoietic progenitors

Targeted Therapy What the Surgeon Needs to Know

HER2 Status: What is the Difference Between Breast and Gastric Cancer?

Superior TrueMAB TM monoclonal antibodies for the recognition of proteins native epitopes

Corporate Medical Policy Molecular Markers in Fine Needle Aspirates of the Thyroid

BRAF as a prognostic marker in papillary thyroid cancer

If and when cancer cells stop dividing, they do so at random points, not at the normal checkpoints in the cell cycle.

Lecture Series 7. From DNA to Protein. Genotype to Phenotype. Reading Assignments. A. Genes and the Synthesis of Polypeptides

Chapter 12: The Cell Cycle

BROMOscan Quantitative Ligand Binding Assays

Introduction. Cancer Biology. Tumor-suppressor genes. Proto-oncogenes. DNA stability genes. Mechanisms of carcinogenesis.

HPV OncoTect E6, E7 mrna Kit A highly specific molecular test for early detection of cervical cancer

Lecture 8. Protein Trafficking/Targeting. Protein targeting is necessary for proteins that are destined to work outside the cytoplasm.

Us TOO University Presents: Understanding Diagnostic Testing

Head of College Scholars List Scheme. Summer Studentship. Report Form

Classificazioni citologiche: verso uno schema internazionale unificato?

Saturation Biopsy for Diagnosis and Staging of Prostate Cancer. Original Policy Date

Transcription:

Regulation of Protein Translation and c-jun expression by Prostate Tumor Overexpressed1 (PTOV1) Verónica Cánovas, PhD Student Laboratory of Cell Signalling and Cancer Progression, Dra. Rosanna Paciucci Research Unit in Biomedicine and Translational Oncology Vall d Hebron Institute of Research (Barcelona, Spain) Regulation of protein translation and c-jun expression by Prostate Tumor Overexpressed 1 (PTOV1) N. Marqués, M. Sesé, V. Cánovas, F. Valente, R. Bermudo, I. de Torres, Y. Fernández, I. Abasolo, P. L Fernández, H. Contreras, E. Castellón, T. Celià-Terrassa, R.l Méndez, S. Ramón y Cajal, T. M. Thomson and R. Paciucci Oncogene. 2013 Mar 4. doi: 10.1038/onc.2013.51.

PTOV1: a novel protein overexpressed in prostate cancer Benign Peripheral Zone High Grade Prostate Intraepithelial Neoplasia Carcinoma 3.4% 80% 71% A and B have 80% homology PTOV1 A B 151aa 147aa 416 aa Benedit et al., Oncogene, 2001 F. Bontems et al., J Struct Biol 2011 PTOV1 is overexpressed in prostate cancers and pre-neoplastic lesions, but it is not detected, or expressed at low levels, in the normal associated tissue (BPZ)

PTOV1 expression in High-Grade PIN predicts prostate cancer in needle biopsy HG-PIN Prostate cancer CTL + PTOV1 is a useful marker for the early diagnosis of prostate cancer Normal prostate CTL - Biopsies with cancer Biopsies without cancer Relationship between PTOV1expression in HG-PIN lesions and the presence of prostate cancer. Morote J. et al., Clin Cancer Res. 2008.

Prostate cancer PTOV1 induces cell proliferation PTOV1 Ki67 High levels of PTOV1 in tumors and in cells lines correlate significantly with a higher proliferative index Santamaría et al., Am J Pathol 2003

PTOV1 is overexpressed in several tumor types, significantly associated to malignancy and to proliferation kidney pancreas glioblastoma bladder colon The overexpression of PTOV1 is significantly associated to tumors with high grade Fernández S. et al., Virchows Arch. 2011

These evidences suggest a pro-oncogenic function of PTOV1 in prostate cancer. To prevent PTOV1 action in cancer we need to know its function and mechanisms of action.

PTOV1 interacts with RACK1, the Receptor of Activated protein C Kinase PTOV1 interacts directly with RACK1, a regulator of PKC and Jun signaling and a component of the 40S ribosome

PTOV1 associates with the 40S ribosome and regulates protein synthesis up Sucrose gradient down The association of PTOV1 with RACK1 and ribosomes influences protein translation in a mtorc1 dependent manner

PTOV1 enhances translation of the c-jun mrna Protein levels mrna levels PTOV1 stimulates c-jun expression by promoting its translation without affecting its mrna levels

PTOV1 promotes c-jun-dependent enhanced motility and invasion in cancer cells Invasion assay High levels of PTOV1 result in increased levels of active c-jun that promotes SNAI1 transcription, ultimately engaging a mesenchymal-like gene program and enhanced cell invasion qpcr Western Blot Chromatin IP

PTOV1 promotes tumorigenesis and metastasis of PC-3 prostate cancer cells PC3 shctl PC3 shptov1 Knockdown of PTOV1 significantly inhibits tumor growth and causes a delay in the metastatic spread of tumor cells.

Concordant expression of high levels of PTOV1 and active c-jun in association with prostate cancer progression. Normal prostate Staining for both PTOV1 and phosphorylated c-jun showed a significant concordance in prostate tumors Metastasis PTOV1 PTOV p-cjun

Conclusions Collectively, our observations suggest that, in the course of malignant progression, prostate tumors express abnormally high levels of PTOV1 to upregulate c-jun translation and activity as a mechanism to enable and promote a full-blown metastatic phenotype.

Lide Alaña Neus Marqués Rosanna Paciucci Verónica Cánovas Acknowledgements Marta Sesé Pedro J. Guijarro Yolanda Puñal Inés de Torres and S. Ramón y Cajal (Department of Pathology, Vall d Hebron Hospital) Yolanda Fernández ( Molecular Imaging Platform CIBBIM-Nanomedicine, Vall d Hebron Institut de Recerca Héctor Contreras ( Laboratory of molecular and cellular andrology,physiology and biophysic, University of Chile) Toni Celià-Terrassa and Timothy M. Thomson ( Department of Cell Biology, CSIC, Barcelona) Raúl Mendez ( Institute for Research in Biomedicin, Parc Cientific, Barcelona Laboratory of Cell Signalling and Cancer Progression, Dra Rosanna Paciucci Research Unit in Biomedicine and Translational Oncology, Vall d Hebron Institut of Research

Yeast two hybrid interactions RACK1 Flotillin-1 PSMB4 BAT4 KIAA0804 eif3ε Receptor for activated PKCIGF-1R/ IR singaling, cell proliferation/ motility Intracellular vesicular transit, IGF-1R/IR receptor signaling Subunit 4b of human proteasome Subunit 4 of HLA-associated transcript 4, G-patch domain RNA binding RING finger domain protein ( E3 ubiquitin ligase Subunit of the traslation initiation factor eif3 Interactions of PTOV1 found by other groups CBP 14-3-3σ Domain BUZ/Znf- UBP Histon acetyl transferase, transcription activation Binding of phosphorilated proteins in the cytoplasm Present in HDAC6, its a E3 ubiquitin binding